1Soloway MS, Briggman JV, Carpinito GA, et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol, 1996,156:363.
2Akaza H, Miyanaga N, Tsukamoto T, et al. Evaluation of urinay NMP22 (nuclear matrix protein 22 ) as a diagnostic marker for urothelial cancer NMP22 as a urinary for surveillance of bladder cancer. Gan To Kagaku Ryoho, 1997,24:829-836.
6Lyderson BK, Pettojohn DE. Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell [J]. Cell, 1980, 22(2 Pt 2):489-499.
7Yang CH,Lambie EJ, Snyder M. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus[J]. J Cell Biol, 1992, 116(6):1303-1317.
8Keesee K, Briggman JV, Thill G, et al. Utilization of nuclear matrix proteins for cancer diagnosis[J]. Crit Rev Eukaryot Gene Expr, 1996, 6(2-3):189-214.
9Hughes JH, Cohen MB. Nuclear matrix proteins and their potential applications to diagnostic pathology[J]. Am J Clin Pathol, 1999, 111(2):267-274.
10Sanchez-Carbayo M, Herrero E, Megias J, et al. Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer [J]. J Urol, 1999, 162(6):1957-1958.
